Secukinumab, an IL-17A antagonist, is marketed by Novartis under the brand name Cosentyx®. In 2023, Cosentyx® observed the sales of 5 billion dollars, inclusive of
Pharmaceutical innovation, drug pricing, and patient access to essential medicines must work in a concerted fashion. Factors like: end up spiking the drug prices. Such
The Ministry of Commerce and Industry released the draft Patents (2nd Amendment) Rules, 2024 on 3rd January 2024. The draft rules focus on establishing a
Biosimilar medicine is a biologic product. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) define a biosimilar product with certain
Patents provide intellectual property rights protection to newly invented products, services, and processes. The patentability criteria involve: To enforce these rights, patents must be registered
The Pharmaceutical Industry of India plays a very important role around the globe. It is one of the largest generic medicine providers in the world.
